Norepinephrine transporter inhibition prevents tilt-induced vasovagal syncope: a randomized, placebo controlled trial

Back

ESC Premium Access

Norepinephrine transporter inhibition prevents tilt-induced vasovagal syncope: a randomized, placebo controlled trial

Session: Poster Session 5 - Syncope

Topic: Drug Treatment

Speaker: Doctor S. Raj (Calgary, CA)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Satish R Raj

Libin Cardiovascular Institute Of Alberta, Calgary (Canada)

3 presentations

1 follower

10 more presentations in this session

Risk predictors of supraventricular tachycardia and bradycardia necessitating therapy in patients with unexplained syncope receiving implantable loop recorder.

Speaker: Doctor T. Onuki (Yokohama, JP)

Access

Abstract

Etiology of syncope in patients with severe aortic stenosis

Speaker: Doctor J. Francisco Pascual (Barcelona, ES)

Access

Abstract

Slides

High incidence of injury due to vasovagal and bradyarrhythmic syncope

Speaker: Doctor P. Pournazari (Calgary, CA)

Access

Abstract

Slides

Sex-specific symptoms in the early diagnosis of syncope

Speaker: Doctor J. Du Fay De Lavallaz (Basel, CH)

Access

Abstract

Diagnostic concordance after long-term follow-up of patients evaluated in a syncope unit

Speaker: Ms P. Guardia Martinez (Malaga, ES)

Access

Abstract

Slides

Access the full session

Poster Session 5 - Syncope

Speakers: Doctor S. Raj, Doctor T. Onuki, Doctor J. Francisco Pascual, Doctor P. Pournazari, Doctor J. Du Fay De Lavallaz...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources